Mercaptopurine
Links shared publicly online about this topic
ingentaconnect Tacrolimus/mercaptopurine: Pneumocystis carinii pneumonia in elde...
ingentaconnect.com — “ingentaconnect Tacrolimus/mercaptopurine: Pneumocystis carinii pneumonia in elde...” View full resource at ingentaconnect.com
Most Recently Shared on December 16, 2010 at 12:23 am By:
Tacrolimus/mercaptopurine: Pneumocystis carinii pneumonia in elderly patients: 2 case reports: (Source: Reactions) http://bit.ly/dY8Rms
FDA Continues Review of Cancer Risk Associated with TNF blockers, Azathioprine, and/or Mercaptopurine - MPR
empr.com — “The FDA continues to receive reports of hepatosplenic T-Cell lymphoma (HSTCL) in adolescents and young adults treated for Crohn--™s disease and ulcerative colitis with tumor necrosis factor (TNF) blockers, as well as azathioprine, and/or mercaptopurine.” View full resource at empr.com
Most Recently Shared on April 14, 2011 at 6:50 pm By:
MPR News: FDA Continues Review of Cancer Risk Associated with TNF blockers, Azathioprine, and/or Mercaptopurine:... http://bit.ly/gT2YaE
CHMP backs Nova Laboratories' Mercaptopurine oral suspension for leukaemia | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on July 29, 2011 at 11:26 am By:
Pharmafocus Health News and Pharma
CHMP backs Nova Laboratories' Mercaptopurine oral suspension for leukaemia http://ow.ly/1e0NYm
Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults
fda.gov — “UPDATED 11/04/2011. FDA is asking health professionals to remain vigilant for cases of malignancy in patients treated with TNF blockers and report them to MedWatch.” View full resource at fda.gov
Most Recently Shared on November 4, 2011 at 5:13 pm By:
#Safety Alert: #TNF blockers, Azathioprine &/or Mercaptopurine: T-Cell Lymphoma in Adolescents/Yg Adults: http://t.co/DLZCCuvf via @AddThis
FDA Drug Safety Communication: Safety Review update on reports of Hepatosplenic T-Cell Lymphoma in adolescents and young adults receiving tumor necrosis factor (TNF) blockers, azathioprine and/or mercaptopurine
fda.gov — “[04-14-2011] The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn--™s disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, as well as with azathioprine, and/or mercaptopurine.” View full resource at fda.gov
Most Recently Shared on April 14, 2011 at 3:02 pm By:
Richard Hom OD MPA Active Health Library, Doctor, and Optometrist
FDA ..Do you have patients taking tumor necrosis factor (TNF) blockers, azathioprine and/or mercaptopurine? Please read http://ow.ly/4AgL6
U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 18, 2011 at 9:07 pm By:
Paul Cacciatore Patient Advocate
U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer http://t.co/YpbOctK
Emergency Med Medical News about Pancreatitis
mdlinx.com — “Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon” View full resource at mdlinx.com
Most Recently Shared on May 27, 2010 at 4:33 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon: Aliment... http://bit.ly/cUyBqm #ER #mdlinx
Gastro Medical News about Pancreatitis
mdlinx.com — “Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 10:37 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon: Alimentary Phar... http://bit.ly/cFUeoY #GI
Gastro Medical News about Inflammatory Bowel Diseases
mdlinx.com — “Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 11:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
GI: Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions... http://bit.ly/arGEDT
Infectious Dis. Medical News about Pancreatitis
mdlinx.com — “Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 11:07 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon: Alimentary Phar... http://bit.ly/cYA0JG #ID
Pediatrics Medical News about leukemia
mdlinx.com — “Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia” View full resource at mdlinx.com
Most Recently Shared on April 29, 2010 at 7:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate... http://bit.ly/9xZfwR #peds
Oncology Medical News about leukemia
mdlinx.com — “Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia” View full resource at mdlinx.com
Most Recently Shared on April 30, 2010 at 12:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotre... http://bit.ly/cFOOT1 #oncology
Oncology Article | Leukemia
mdlinx.com — “Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukemia. A Nordic Society of Pediatric Hematology and Oncology (NOPHO) pilot study” View full resource at mdlinx.com
Most Recently Shared on August 24, 2011 at 9:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidati... http://t.co/7oK8ORx #oncology
Medications used to treat Ulcerative Colitis | MediGuard
mediguard.org — “Medications used to treat Ulcerative Colitis | MediGuard” View full resource at mediguard.org
Most Recently Shared on August 5, 2011 at 3:17 pm By:
MediGuard.org Health Organization
MediGuard - tracking over 14799 patients with #ulcerative_colitis ... http://tinyurl.com/4ubof4k
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
Advertisement
